GlassScriptPhysician profile
Nilesh Patel
NPI 1851656318
$8,510.76
in general payments reported to CMS, 2019-2025
12 companies · $486 in 2025
The $486 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,557 · 2020: $669 · 2021: $948 · 2022: $829 · 2023: $1,226 · 2024: $1,795 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,867 · Travel and Lodging: $640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,867.30 |
| Travel and Lodging | $640.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,716.58 | 2019-2025 | Prostep, Hoffmann, Prostep Mica |
| Smith+Nephew, INC. | $1,008.01 | 2019-2020 | |
| Paragon 28, INC. | $197.72 | 2025 | Portfolio, Smart28 |
| Medtronic, INC. | $186.97 | 2022 | |
| Bone Support INC. | $128.64 | 2025 | Cerament G, Ceramentbone Void Filler |
| Depuy Synthes Sales INC. | $92.21 | 2024-2025 | Motoband |
| Organogenesis INC. | $78.77 | 2019 | |
| Arbor Pharmaceuticals, INC. | $37.43 | 2019 | |
| Bioventus LLC | $32.61 | 2019-2021 | |
| Melinta Therapeutics, LLC | $13.54 | 2019 | |
| Cardinal Health 200 LLC | $12.87 | 2019 | |
| Grt US Holding, INC. | $5.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nilesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.